Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Firestone Institute of Respiratory Health, The Research Institute of St. Joes, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Am J Respir Crit Care Med. 2023 Feb 15;207(4):427-437. doi: 10.1164/rccm.202206-1183OC.
Localized autoimmune responses have been reported in patients with severe eosinophilic asthma, characterized by eosinophil degranulation and airway infections. To determine the presence of autoantibodies against macrophage scavenger receptors within the airways and their effects on macrophage function and susceptibility to infection. Anti-EPX (eosinophil peroxidase), anti-MARCO (macrophage receptor with collagenous structure) IgG titers, and T1 and T2 (type 1/2) cytokines were measured in 221 sputa from 143 well-characterized patients with severe asthma. Peripheral monocytes and MDMs (monocyte-derived macrophages) isolated from healthy control subjects were treated with immunoprecipitated immunoglobulins from sputa with high anti-MARCO titers or nonspecific IgG to assess uptake of or response to the bacterial product LPS. Anti-MARCO IgG was detected in 36% of patients, with significantly higher titers (up to 1:16) in patients with mixed granulocytic sputa, indicative of airway infections. Multivariate regression analysis confirmed increased frequency of degranulation (free eosinophil granules), increased blood eosinophils (indicative of high T2 burden), increased sputum total cell count, peripheral blood leukocytes (indicative of infection), and lymphopenia were associated with increased anti-MARCO IgG titers; IL-15 (odds ratio [OR], 1.79; confidence interval [CI], 1.19-2.70), IL-13 (OR, 1.06; CI, 1.02-1.12), and IL-12p70 (OR, 3.34; CI, 1.32-8.40) were the associated cytokines. Patients with anti-MARCO antibodies had higher chances of subsequent infective versus eosinophilic exacerbations ( = 0.01). MDMs treated with immunoprecipitated immunoglobulins (anti-MARCO sputa) had reduced bacterial uptake by 39% ± 15% and significantly reduced release of IL-10 and granulocyte-macrophage colony-stimulating factor (GM-CSF) ( < 0.05) in response to an LPS stimulus. Autoantibodies against macrophage scavenger receptors in eosinophilic asthma airways may impede effective host defenses and lead to recurrent infective bronchitis.
在严重嗜酸性粒细胞性哮喘患者中,已报道存在局部自身免疫反应,其特征为嗜酸性粒细胞脱颗粒和气道感染。为了确定气道内是否存在针对巨噬细胞清道夫受体的自身抗体及其对巨噬细胞功能和易感性感染的影响。在 143 名特征明确的严重哮喘患者的 221 份痰中,测量了抗 EPX(嗜酸性粒细胞过氧化物酶)、抗 MARCO(具有胶原结构的巨噬细胞受体)IgG 滴度以及 T1 和 T2(1/2 型)细胞因子。从健康对照者中分离出外周单核细胞和 MDM(单核细胞衍生的巨噬细胞),并用高抗 MARCO 滴度的痰液免疫沉淀免疫球蛋白或非特异性 IgG 处理,以评估摄取或对细菌产物 LPS 的反应。在 36%的患者中检测到抗 MARCO IgG,在混合粒细胞性痰液患者中,滴度显著升高(高达 1:16),提示气道感染。多变量回归分析证实,脱颗粒(游离嗜酸性粒细胞颗粒)、血嗜酸性粒细胞增加(提示 T2 负担高)、痰总细胞计数增加、外周血白细胞增加(提示感染)和淋巴细胞减少与抗 MARCO IgG 滴度增加相关;IL-15(比值比 [OR],1.79;置信区间 [CI],1.19-2.70)、IL-13(OR,1.06;CI,1.02-1.12)和 IL-12p70(OR,3.34;CI,1.32-8.40)是相关的细胞因子。抗 MARCO 抗体患者发生后续感染性与嗜酸性粒细胞性恶化的可能性更高( = 0.01)。用免疫沉淀免疫球蛋白(抗 MARCO 痰液)处理的 MDM,细菌摄取减少 39%±15%,并显著减少对 LPS 刺激的 IL-10 和粒细胞-巨噬细胞集落刺激因子(GM-CSF)的释放( < 0.05)。在嗜酸性粒细胞性哮喘气道中针对巨噬细胞清道夫受体的自身抗体可能会阻碍有效的宿主防御并导致反复感染性支气管炎。